What happens when you discontinue semaglutide

Why stopping often leads to weight regain, and what the evidence says

The body's appetite-regulating systems don't stay switched off once treatment ends. Semaglutide works by mimicking GLP-1, a gut hormone that signals fullness and slows the rate at which the stomach empties, and if you're curious about how semaglutide was discovered and why it works this way, the story behind its development is worth reading. While you're taking it, hunger is noticeably quieter for most people. When the medicine is withdrawn, those signals recover, sometimes within weeks.

The clearest evidence comes from the extension phase of the STEP 1 trial, published in the New England Journal of Medicine. Participants who stopped semaglutide 2.4mg after 68 weeks regained, on average, around two-thirds of the weight they had lost over the following year. Cardiometabolic markers (blood pressure, blood sugar levels, cholesterol) also moved back toward where they had been before treatment started. This doesn't mean stopping was the wrong choice for everyone in that trial, but it is the baseline fact worth holding in mind as you consider your options.

One practical check: if you're unsure whether treatment is still working for you, weigh yourself at the same time of day, on the same scales, for four consecutive weeks. A consistent plateau isn't necessarily a reason to stop (dose titration may still be an option) but it's a clear conversation starter with your prescriber.

When stopping is the right clinical call

There are situations where discontinuing is the right and medically appropriate step. Pregnancy planning is one of the most clear-cut: semaglutide is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. The MHRA advises using reliable contraception during treatment and for a wash-out period before trying to conceive; the exact timeline should come from your prescriber, not a general article.

Planned surgery is another situation where stopping in advance is standard practice. Anaesthetists need to know you're on a GLP-1 medicine because of the effect on gastric emptying; NHS England's guidance on weight-management injections specifically advises informing your whole clinical team, including the anaesthetist, before any procedure.

Some people stop because side effects (typically gastrointestinal: nausea, loose stools, reflux) haven't settled as expected. For others, the decision is financial or logistical. Whatever the reason, the underlying principle is the same: stopping is a clinical event, not just skipping a pen. A prescriber can help you plan it properly, whether that means a gradual approach or a clear stopping point.

If you're thinking about who semaglutide is suited to or whether a different licensed medicine might fit your situation better, that assessment is worth having with a clinician before making a change.

What to expect in the weeks after your last dose

The medicine's effects don't disappear overnight. Semaglutide's half-life means it takes several weeks to clear fully, and some appetite suppression may linger briefly before hunger returns more forcefully. Many people notice increased appetite and food cravings in the four to eight weeks after their last injection, this is a recognised pharmacological effect, not a sign that something has gone wrong.

The NHS medicines page for semaglutide is a useful, plain-language reference for what the medicine does and what stopping it involves. If side effects were the reason you stopped, it's worth noting which ones improved and which didn't, that information is directly relevant if you return to treatment later or try a different medicine.

Weight regain tends to be gradual rather than sudden for most people, but the trajectory is usually upward. Lifestyle habits built during treatment (particularly protein intake, regular meals, and activity) can slow that trajectory, though evidence suggests they don't eliminate it entirely in people with a BMI that qualifies them for pharmacological treatment. For context on Wegovy (semaglutide) as an ongoing treatment, and what a continuing plan looks like, the main Wegovy page covers the licensing and clinical background in more detail.

Restarting semaglutide: what that looks like in practice

Many people who stop do return to treatment, sometimes after a gap of weeks or months. Coming back to semaglutide after a break isn't simply picking up where you left off. Prescribing practice typically involves restarting at a lower dose and titrating again, because tolerance to the gastrointestinal side effects diminishes during a break. Starting back at the highest previous dose is associated with a higher likelihood of nausea and vomiting.

If you stopped because you were unable to access your supply rather than by choice, the restart process is the same. Supply constraints have affected availability at times, and a prescriber can advise on the appropriate re-entry point based on how long the gap was. That clinical review matters, it's the step that protects you from the effects of jumping back in too fast.

For anyone considering returning to a regulated private prescription route, you can read about weight-loss treatment options available through a licensed UK pharmacy, or check what the cost picture for Wegovy in the UK looks like, since pricing has shifted since Eli Lilly's list-price changes in mid-2025. When you're ready to speak to a prescriber directly, starting a free consultation is the straightforward next step, a real clinician reviews your answers the same day.